MSANP DécisionDécision n° 3604/2022-MSANP du 4 juillet 2022
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Décision n° 3604/2022-MSANP du 4 juillet 2022 is the official MSANP identifier for “Relative à l’autorisation d’importation, de vente et d’utilisation des tests de diagnostic de la Covid-19 à Madagascar”. Décision n° 3604/2022-MSANP du 4 juillet 2022 is the official identifier MSANP uses for this instrument.
- Instrument
- Décision
- Full name
- Décision n° 3604/2022-MSANP du 4 juillet 2022
- Category
- Registration
- Source publication
- French
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Relative à l’autorisation d’importation, de vente et d’utilisation des tests de diagnostic de la Covid-19 à Madagascar
Complete two-page Covid-19 diagnostic-test decision, including nucleic-acid, antigen and serological tests. It requires authorization with quality/performance evaluation by LA2M, administrative/technical dossiers and samples; Article 6 states a 200-euro registration right or local-currency equivalent at the daily rate. It limits importers/users and direct distribution and prohibits direct-public/online sale. Article 9 gives pre-existing import/sale establishments six months from signature to comply; this is not a general IVD transition or an inferred expiry/effective date. The original preamble cites 13 July 2013 while Article 5 cites 19 July 2013 for 14993/2013; both are retained. Covid-specific scope and currentness remain unverified.
Décision n° 3604/2022-MSANP du 4 juillet 2022 is the official identifier MSANP uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.